Stealth BioTherapeutics Corp Stock News

Thinly traded nano cap Stealth BioTherapeutics (NASDAQ:MITO) jumps 74% premarket on increased volume in reaction to its announcement that the FDA has granted Rare Pediatric Disease designation for e

Gainers Stealth BioTherapeutics, Inc. (NASDAQ: MITO) shares surged 74.2% to $3.31 during Tuesday's pre-market session. According to the most recent rating by H.C....

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfu

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfu

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst

Stealth BioTherapeutics (NASDAQ:MITO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, �

Shares of Stealth BioTherapeutics Corp (NASDAQ:MITO) have been given an average recommendation of “Buy” by the eight brokerages that are covering the stock, Marketbeat Ratings reports. Three equit

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia

Stealth BioTherapeutics (NASDAQ:MITO)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a research note issued on Tuesday, The Fly reports. They currently have a $10.00 target

Bellerophon Therapeutics (NASDAQ:BLPH) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hy

Thinly traded nano cap Stealth BioTherapeutics (NASDAQ:MITO) is up 34% premarket on increased volume in reaction to positive results from a retrospective natural history study assessing the efficacy

Gainers Stealth BioTherapeutics, Inc. (NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H...

Stealth BioTherapeutics (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfu

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS